Key Updates in Clinical Guidelines for CKD Testing in Patients With Type 2 Diabetes

Author(s):

Rajiv Agarwal, MD,Mark A. Meeker, DO, FACP, CPE

Key Takeaways

Early and regular CKD testing in type 2 diabetes patients is crucial for timely intervention and management.
eGFR and UACR are recommended for comprehensive assessment of kidney function and damage.
SGLT2 inhibitors and GLP-1 receptor agonists are emphasized for their nephroprotective benefits in managing CKD progression.

Panelists discuss key updates in clinical guidelines for chronic kidney disease (CKD) testing in patients with type 2 diabetes, highlighting the latest recommendations for improving screening and diagnosis.

What are the key updates in clinical guidelines for CKD testing in patients with type 2 diabetes?